SCHEDULE 13G/A: BlackRock Amends Stake in Prestige Consumer Healthcare, Disclosing 15.2% Beneficial Ownership

BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reporting a 15.2% beneficial ownership stake in Prestige Consumer Healthcare Inc. as of March 31, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 15 to its Schedule 13G regarding its beneficial ownership in Prestige Consumer Healthcare Inc.
• As of March 31, 2025, BlackRock, Inc. beneficially owned an aggregate of 7,524,587 shares of Prestige Consumer Healthcare Inc. common stock.
• This ownership represents 15.2% of the class of securities.
• BlackRock holds sole voting power over 7,423,766 shares and sole dispositive power over 7,524,587 shares.
• No shared voting or dispositive power was reported.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• One of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, holds more than 5% of the total outstanding common stock of Prestige Consumer Healthcare Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook. It is a neutral, compliance-driven filing.

Positives

• Significant institutional investment from BlackRock, a major global asset manager, indicates confidence in Prestige Consumer Healthcare Inc.
• BlackRock's certification that the stake is for ordinary course of business and not for control purposes suggests a stable, long-term investment perspective.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

This filing reflects a routine disclosure by a major institutional investor, BlackRock, Inc., regarding its significant passive stake in Prestige Consumer Healthcare Inc. Such filings are common in the asset management industry as large funds manage diversified portfolios and are required to disclose holdings exceeding 5% in publicly traded companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holding by BlackRock may provide a degree of stability and confidence, as it indicates a major investor's continued interest in the company.

Key Dates

Keywords

BlackRock, Prestige Consumer Healthcare Inc., Schedule 13G, beneficial ownership, institutional investor, common stock, asset management, investment filing, SEC filing, equity stake